The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / MicroRNA Mediates Gene Regulation That Underlies JIA Pathology

MicroRNA Mediates Gene Regulation That Underlies JIA Pathology

July 25, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Gio.tto_Shutterstock_DNASequence_500x270Patients with juvenile idiopathic arthritis (JIA) and cystic fibrosis (CF) experience chronic, indolent inflammation that makes it difficult to determine whether their immunological abnormalities are truly pathological or a predictable, physiological adaptation to chronic inflammation in soft tissues. Researchers are developing tools to address this distinction. Specifically, projects from the National Institutes of Health, such as the Encyclopedia of DNA Elements (ENCODE) and Roadmap Epigenomics, have made it possible to address the question of pathophysiology vs. immunological adaptation via eukaryote transcriptomes. Data from these large, complex studies would suggest that transcriptome analysis will allow for a network approach to describing pathogenesis. In particular, the studies have fueled a growing understanding of the role microRNA (miRNA) plays in the mediation of gene regulation via destabilizing target transcripts.

You Might Also Like
  • Large Group Study of Systemic JIA Patients Provides Insight into Disease Pathology
  • Circulating MicroRNA Provides Clues to Class IV Lupus Nephritis
  • MicroRNA-Based Therapeutics Hold Promise Against Lupus, Other Rheumatic Diseases Note Experts at the ACR/ARHP’s 2013 Annual Meeting
Also By This Author
  • Exercise Therapy May Take the ‘Tired’ Out of Chronic Fatigue Syndrome

New research has leveraged insights into transcriptomes and shed light on the connection between genes, non-coding transcripts and disease phenotypes. Zihua Hu, PhD, a bioinformatics computational scientist of the State University of New York in Buffalo, and colleagues published the results of their transcriptome analysis online on June 7 in Scientific Reports.1 They found that neutrophils have transcriptional repertoires that are specific to different pathological/physiological contexts and increased our understanding of the role of innate immunity in JIA pathology. Dr. Hu and colleagues demonstrated that miRNAs have a global effect on the neutrophil transcriptome, thereby revealing that cells known for their non-specific responses can tailor their transcriptional repertoire to specific physiologic and pathologic contexts.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“In this study, we examined transcriptional complexity in neutrophils of children with three distinct phenotypes: juvenile idiopathic arthritis, cystic fibrosis and healthy children seen in a well-child clinic,” write the authors in their paper. “We have previously shown that neutrophils of children with JIA show distinct transcriptional abnormalities that are associated with evidence of chronic activation and perturbation of fundamental metabolic processes. These transcriptional abnormalities do not correct when children achieve clinically inactive disease and maintain that state for six consecutive months.”

Based on this previous work, the investigators designed the current study, which used exon and miRNA hybridization-based microarrays to generate mRNA, gene isoform and miRNA expression profiles for the three phenotypes. They then performed hierarchical cluster analyses on the expression data from genes, isoforms and miRNA. When they performed enrichment analyses, they found that the differentially expressed genes in children with JIA were associated with alternative splicing, cytoskeleton, phosphoproteins and repeat regulatory proteins.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We also demonstrate that the transcriptomes of neutrophils in chronic inflammatory states show extensive network ‘rewiring’ that is orchestrated by miRNA. The complexities of such miRNA-mRNA networks have been described previously, and even small variations in the number of miRNA molecules or their target mRNAs can have significant effects on network structure and protein translation,” explain the authors. Thus, their work, in combination with a previously published distinct network approach to understanding JIA, suggests a role for alternative splicing in JIA pathogenesis. The investigators acknowledge, however, that their data can provide only a snapshot of what is likely to be a highly complex and dynamic process.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: cystic fibrosis, JIA, juvenile idiopathic arthritis (JIA), microRNA, neutrophil, neutrophil transcriptome

You Might Also Like:
  • Large Group Study of Systemic JIA Patients Provides Insight into Disease Pathology
  • Circulating MicroRNA Provides Clues to Class IV Lupus Nephritis
  • MicroRNA-Based Therapeutics Hold Promise Against Lupus, Other Rheumatic Diseases Note Experts at the ACR/ARHP’s 2013 Annual Meeting
  • What Do JIA Patients Experience? A New Case Study from the ARP Practice Committee

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.